Renown Health Patients and Visitors

RENOWN NEWSROOM

Latest News Releases

Featured News

Careers

Awards & Accreditations

University of Nevada, Reno

Renown Health Foundation



Media Resources

Renown Public Relations Media Icon
Renown Health's Public Relations Team
news@renown.org

Renown Health's public relations team supports media partners in finding experts on diverse health care topics. In addition, we provide information and answer all questions regarding Renown. We look forward to working with you.

Read MoreMedia Resources
  • Media On Campus

    For patient confidentiality purposes, Renown Health policies require media to be escorted by the public relations staff at all times.

    PR staff will gladly make parking arrangements, notify the appropriate hospital staff and help you find your destination.

     

    Stand Ups/Live Broadcasts

    Media may conduct stand ups and live broadcasts on our campuses. In the interest of patient confidentiality and traffic flow, a staff member will help you find the best location for your story.

    We ask you to respect our obligation to protect our patients' well-being and legal right to privacy.

  • Patient Condition Inquiry

    We follow regulations of the Health Insurance Portability and Accountability Act of 1996 (HIPAA) for all patients, including patients of public interest. HIPAA regulations specify which information may and may not be released without authorization from a patient.

    Patient privacy regulations allow us to only share patient condition information about patients that appear in our directory.

    Media inquiries require correct spelling of the patient's first and last name.

     

    Definitions of "Condition" used by Renown Health

    When describing a patient's condition, we can only release the following patient statuses:

    Good - Vital signs such as pulse, temperature and blood pressure are stable and within normal limits. Patient is conscious, comfortable and there are no complications.

    Fair - Vital signs are stable and within normal limits. Patient is conscious and alert although may be uncomfortable or in pain and may have minor complications.

    Serious - Vital signs may be unstable or outside normal limits. The patient is acutely ill or injured and may have major complications.

    Critical - Vital signs are unstable or outside normal limits. There are major complications.

    Note: "Stable" is not a condition.

Press Releases

Number of results found: 35
Use this additional navigation to go to the next pages. Use tab and enter keyboard keys to navigate the menu 1 Page # 2 Page # 3 Navigate to next page Page 1 of 3
Skipped to 35 results found. Page 1 of 3
    • Wednesday, Mar 06, 2024

    Research Shows Genetic Approaches to Breast Cancer Screenings Yield More Accurate Results

    Clinical researchers with the Healthy Nevada Project co-author research paper with findings that emphasize the need for a comprehensive approach to breast cancer risk assessment – including a focus on genetic medicine – to help ensure that individuals at high risk are identified and supported proactively rather than reactively.  Breast cancer is a leading cause of cancer death among women in the United States. According to the American Cancer Society, about 1 in 8 women will develop breast cancer and about 1 in 39 women will die from breast cancer. Breast cancer is associated with increased age, hereditary factors, obesity, and alcohol use. Since 1990, breast cancer death rates have declined progressively due to advancements in treatment and detection. In Nevada there are an estimated 2,310 new breast cancer cases a year, and genetic mutations such as in the genes BRCA1 or BRCA2 remain a top risk factor for this prevalent disease. Recognizing the urgency for progress in breast cancer research, a collaborative effort between physicians, advanced practice providers and scientists from the Healthy Nevada Project® (HNP) and Helix have unveiled groundbreaking research. This study explores how genetic screenings are a necessary supplement to traditional testing methods, together offering more accurate insights into a patient's likelihood of developing breast cancer in the future. HNP is operated by Renown Genomic Medicine and the Institute for Health Innovation and is one of the largest community-based population health studies in the country. Their team works in collaboration with Helix, a leader in precision health that delivers comprehensive genomic solutions. Together, this dynamic partnership aims to understand breast cancer risk factors and pave the way for more effective preventative measures. The combined research team studied 25,591 female HNP participants to evaluate the performance of different genetic screening approaches to identify women at high risk of breast cancer. The results of this research suggest that a combined monogenic, or single-gene, and polygenic, or multi-gene, approach to breast cancer screenings helped produce more accurate results and more closely identify study participants who have a high genetic risk of developing the disease. "Based on this research, we are advocating a shift in approach which would improve breast cancer risk assessment through a combination of effective family history ascertainment and genetic screening,” said Joseph Grzymski, PhD, principal investigator of the Healthy Nevada Project, research professor at the University of Nevada, Reno School of Medicine and co-author of the breast cancer research paper. “This tailored approach, founded on the assessment of individual genetic risk, not only intends to elevate patient well-being but also will improve efficiency and equity in healthcare." Complementing the team’s research on leveraging genetics to identify women at low genetic risk of breast cancer that could safely defer mammogram screenings by five to 10 years that was released in late 2023 in JAMA Oncology, the study suggests that incorporating genetic information can assist in personalizing breast cancer screenings and optimizing the use of screening resources. "Existing disparities persist across various facets of breast cancer screening and treatment; however, genetic screening is clearly a powerful tool to help facilitate early intervention for those at higher risk,” said Jamie Schnell Blitstein, APRN, a primary care nurse practitioner at Renown Health and co-author of the breast cancer research paper. “By placing a heightened focus on risk, we underscore the pivotal role of preventative breast cancer screening.” Despite the availability of effective methods for early screening, co-authors of this research found that 78 percent of women with a family history of breast cancer had their risk ascertained only after a breast cancer diagnosis. The findings emphasize the need for a comprehensive approach to breast cancer risk assessment – including a focus on genetic medicine – to help ensure that individuals at high risk are identified and supported proactively rather than reactively.  “These findings that can profoundly impact how healthcare is delivered were only made possible by all the participants who were willing to consent to research,” said Alex Bolze, PhD from Helix and co-author of the publication. “Broad-scale collaboration projects like these between Renown Health and UNR that engage large populations where participants share both their genetic information as well as electronic health records drive advancements in preventative medicine, as well as fundamental biological research.”   The research paper was officially accepted on Jan. 29, 2024, and will be published by Elsevier, Inc. on behalf of the American College of Medical Genetics and Genomics. The contents of the paper will appear in the international journal Genetics in Medicine Open. Read the full article by visiting sciencedirect.com. The Healthy Nevada Project is currently recruiting new study participants. Free to all Nevadans with a saliva sample or blood draw, participants and their referring providers receive access to whole-exome sequencing and clinical grade results that help provide insight into their unique genetic risks tied to heart disease and certain cancers. If you are interested in enrolling in the study, schedule a Virtual Consent Appointment through MyChart or contact the Renown Institute for Health Innovation at RenownIHI@renown.org or (775) 982-6914 to be connected to a Genomic Representative. About Renown Health Renown Health is the region’s largest, not-for-profit integrated healthcare network serving Nevada, Lake Tahoe and northeast California. With a diverse workforce of more than 7,000 employees, Renown has fostered a longstanding culture of excellence, determination and innovation. The organization comprises a trauma center, two acute care hospitals, a children’s hospital, a rehabilitation hospital, a medical group and urgent care network, and the region’s largest, locally owned not-for-profit insurance company, Hometown Health. Renown is currently enrolling participants in the largest community-based genetic population health study, the Healthy Nevada Project®. To join the Renown Health team, visit renown.org/careers. About Helix Helix is the leading population genomics and viral surveillance company operating at the intersection of clinical care, research, and data analytics. Helix enables health systems, life sciences companies, payers, and government partners to accelerate the integration of genomic data into patient care and public health decision-making. Learn more at helix.com.

    Read More About Research Shows Genetic Approaches to Breast Cancer Screenings Yield More Accurate Results

    • Monday, Jan 29, 2024

    Exceptional Talent Joins William N. Pennington Cancer Institute at Renown; Dr. Kate Ward Brings Expertise and Vision as Vice President of Oncology Division

    Renown Health is pleased to announce that Kate A. Ward, Pharm.D., BCPS, has been promoted to serve as Vice President, Oncology for Renown Regional Medical Center.    Dr. Ward has over fourteen years of service to the organization, most recently as Director of Clinical Pharmacy responsible for the oversight of all clinical pharmacy activities at Renown Regional Medical Center, Renown South Meadows Medical Center, and Renown Rehabilitation Hospital. Additionally, Dr. Ward is the Residency Director of the Post-Graduate Year 1 (PGY1) Pharmacy Practice Residency at Renown. Over the last decade at Renown, Dr. Ward has served as Pharmacy Clinical Manager, Pharmacy Clinical Coordinator and Clinical Pharmacist.   Dr. Ward will bring her pharmacy clinical service experience (including ICU, Outpatient Infusion, Pediatrics, Oncology and Emergency Services), Inpatient Care, Clinical Research, and Hospital Formulary Management, Electronic Medical Record Integration and Optimization to this important new role.   As a dyad partner with Max J. Coppes, MD, PhD, MBA, Director of the William N. Pennington Cancer Institute at Renown, she will bring her clinical, operational, regulatory, and administrative experience to lead the oncology division. Dr. Ward, Dr. Coppes and the dedicated team will advance Renown’s mission to expand care, prevention, screening, research, and education with the goal of establishing the first National Institutes of Health, NCI designated Cancer Center for our State.   “We are thrilled to welcome Dr. Ward as our new Vice President of Oncology. She brings a wealth of experience and a passion for advancing patient care. Dr. Ward will play a pivotal role in sharing the future our oncology division and furthering our commitment to providing exceptional care,” said Chris Nicholas, CEO of Renown Regional Medical Center.    As a licensed pharmacist, Dr. Ward holds a Doctor of Pharmacy degree from the University of Colorado, Health Sciences Center. The Pharm.D. is a professional degree like a Doctor of Medicine (MD) or Doctor of Dental Surgery (DDS). As a doctorate, it represents the increasing responsibility pharmacists have in healthcare systems and the high trust Americans have in pharmacists.    Dr. Ward completed her residency at Stanford Hospital and Clinics. She graduated from the University of Nevada, Reno with her bachelor’s degree in Nutritional Sciences. Dr. Ward is active in several professional associations and currently serves as a Pharmacy Board member for HealthTrust; Vice Chair of the American Society of Health System Pharmacists® Council on Therapeutics; and Vice Chair for the Silver State Scripts Board for the State of Nevada. Dr. Ward was the 2022 recipient of the Nevada Society of Health System Pharmacists (NVSHP) President’s Award. About Renown Health Renown Health is the region’s largest, locally governed, not-for-profit integrated healthcare network serving Nevada, Lake Tahoe and northeast California. With a diverse workforce of more than 7,000 employees, Renown has fostered a longstanding culture of excellence, determination and innovation. The organization comprises a trauma center, two acute care hospitals, a children’s hospital, a rehabilitation hospital, a medical group and urgent care network, and the locally owned not-for-profit insurance company, Hometown Health. To join the Renown Health team, visit renown.org/careers.

    Read More About Exceptional Talent Joins William N. Pennington Cancer Institute at Renown; Dr. Kate Ward Brings Expertise and Vision as Vice President of Oncology Division

    • Tuesday, Dec 19, 2023

    Give the Gift of Health This Season with ELF Testing

    Renown Health and the University of Nevada, Reno School of Medicine give the gift of early diagnosis and disease prevention this holiday season.   With the season of giving upon us, give yourself the gift of health. The Renown Institute for Health Innovation (IHI) and the University of Nevada, Reno School of Medicine (UNR Med) are excited to offer a free Enhanced Liver Fibrosis (ELFTM) test to patients at risk for a common type of liver disease, e.g. metabolic and nonalcoholic steatohepatitis (M/NASH), and who enroll or are currently enrolled in the Healthy Nevada Project. The ELF Test is an FDA (Food and Drug Administration) approved non-invasive test to help identify people most at risk for liver scarring, e.g. cirrhosis, and allows doctors to intervene before irreversible damage occurs. If undetected and untreated, M/NASH can result in liver cirrhosis which could require liver transplantation or lead to death. This test is important as the symptoms of M/NASH can be silent or non-specific, making it difficult to diagnose.  “There are currently more than 11,000 people across the U.S. on the national liver transplant waiting list, and with the heightened prevalence of NAFLD and M/NASH, this number is projected to keep rising; however, with research such as the ELF Test at our disposal, we are continuing to find ways to improve the health of those at risk for advanced liver disease,” said Bill Plauth, MD, Chief Medical Officer for Renown Health and Associate Dean of Clinical Affairs at UNR Med. “We encourage our community to participate in this early risk detection. Through this sophisticated, noninvasive, blood test, our physicians and Advanced Practice Providers can better evaluate liver fibrosis to help those affected and enable researchers to improve the prevention and treatment of nonalcoholic liver disease as a whole.”  This liver health-focused sub-study of the Healthy Nevada Project seeks to enhance the understanding of both NAFLD and M/NASH and to help inform the development of treatment options for these conditions, as few currently exist. “Providing access to cutting-edge innovations such as the ELF Test is critical for both participants and the physicians and advanced practice providers that care for them.” said Joseph Grzymski, PhD, principal investigator of the Healthy Nevada Project and the Liver Disease Study and research professor at UNR Med. Those interested in determining their risk for M/NASH and its progression are encouraged to enroll in the Metabolic & Nonalcoholic Steatohepatitis study. Those who have consented and participated in the M/NASH research will be eligible and contacted with more information on how to receive the ELF Test. The Renown IHI is also happy to connect with physicians and Advanced Practice Providers interested in having their patients enroll in the Healthy Nevada Project and join the study. For members of the community who would like more information and learn how to enroll, please contact the Renown IHI at RenownIHI@renown.org or (775) 982-6914 to be connected to a Genomic Representative. About the ELF™ Test  The ELF Test is a noninvasive blood test that can quickly identify which patients are at an elevated risk for developing cirrhosis and other liver-related clinical events (LREs). In contrast to standard liver enzyme tests that reflect liver damage that has already occurred, the ELF Test combines three serum direct biomarkers of active fibrosis. The ELF Test algorithm measures each of these biomarkers to create an ELF score, which can be used as an aid to assess the risk for future disease progression. Doctors may use this ELF score to help evaluate if a patient requires increased medical care and monitoring for their condition. Individuals interested in determining their risk for NASH and its progression are encouraged to enroll in the Nonalcoholic Steatohepatitis Liver Disease Genome Atlas study. Those who have already consented and participated in the study will be contacted with more information on how to receive an ELF blood test. For more information or to enroll, please contact RenownIHI@renown.org or (775) 982-6914. In the U.S., the ELF Testing Service is available from Brio Clinical, Inc., a CLIA-certified laboratory offering specialized testing throughout the United States. Brio Clinical is regulated under CLIA as qualified to perform high complexity testing.

    Read More About Give the Gift of Health This Season with ELF Testing

    • Friday, Dec 01, 2023

    Samuel Austin Lee, M.D., Ph.D., Appointed Chair of Internal Medicine

    Samuel Austin Lee, M.D., Ph.D., FIDSA has joined the University of Nevada, Reno School of Medicine (UNR Med) and Renown Health as Department Chair of Internal Medicine. Dr. Lee comes to Nevada from New England, where he served as Chief of Medicine for the White River Junction (VT) Veteran’s Administration Medical Center and Professor of Medicine at the Geisel School of Medicine at Dartmouth.  Dr. Lee previously served as an Assistant Professor of Medicine in the Division of Infectious Diseases at the University of Texas Health Science Center at San Antonio, and a member of the San Antonio Center for Medical Mycology.  He next served on the faculty for University of New Mexico, as Section Chief, Infectious Diseases at the VA Albuquerque Medical Center, and as Medical Director of the HIV clinic at the VA Albuquerque.  Dr. Lee will serve as the joint academic and administrative leader defining clinical operations to expand care; enhancing teaching and training programs vital to ambulatory and acute care medicine in northern Nevada, and fostering clinical and translational research and diversity missions. Dr. Lee will also serve as the liaison to the VA Sierra Nevada Health Care System, expanding the 30-year academic partnership to enhance general internal medicine and specialty services critical to the community. “We are delighted to have Dr. Lee join us,” said Paul J. Hauptman, MD, Dean of UNR Med and Chief Academic Officer for Renown Health. “He has a strong background in academic medicine, demonstrated excellence in clinical care, medical education and research, and is universally respected as a compassionate physician leader. Dr. Lee will do much to advance the mission of UNR Medicine’s Internal Medicine Residency program and expand related Graduate Medical Education opportunities, thereby helping to train the next generation of physicians.”  “Dr. Lee is a collaborative physician, researcher and mentor who cares deeply about improving the health of our community,” said Brian Erling, MD, MBA, President and CEO, Renown Health. “This is an exceptionally exciting time for him to help craft our vision to offer more efficient and affordable care, elevate the patient experience, and advance health equity across northern Nevada. He will further elevate our mission of outstanding care, exceptional training, innovative research, impactful advocacy, and innovative community partnerships. We are fortunate to have him joining our team and community.” Dr. Lee will oversee the Division Chiefs of Acute Hospital Services at Renown Regional Medical Center, numerous subspecialists across Renown Medical Group, and the Healthy Nevada Project®. He will serve as an active internist and infectious disease subspecialist.  Dr. Lee is a graduate of the seven-year Combined BA/MD Program at Boston University. He completed his internship and residency at the Hospital of the University of Pennsylvania. He then trained in a three-year research track fellowship in Infectious Diseases at Yale University School of Medicine and continued at Yale as a Staff Physician at the VA Connecticut Healthcare System. He obtained his Ph.D. in Investigative Medicine in Yale University’s Graduate School. Dr. Lee’s research explores fungal pathogenesis, secretion, virulence, biofilm formation and antifungal drug discovery. His laboratory work, which has been supported by the National Institute of Allergy and Infectious Diseases (NIAID) and Department of Veterans Affairs Merit awards, involves research on fungal pathogenesis, novel antifungal therapies and treatment approaches against biofilm formation in Candida species, including drug repurposing, high-throughput screening of small molecule compound libraries, and studies of antifungal lock therapies for prevention of catheter-associated infections.  Dr. Lee is recognized for his passion for high-quality patient care and supports future practitioners through rigorous and culturally informed undergraduate and graduate medical education, research, and community collaboration. He maintains active involvement in national committees and editorial boards including Frontiers in Cellular and Infection Microbiology, Plos ONE, Mycopathologia, Virulence, and The Journal of Mycology and is a member of the Peer Review Board for the Journal of Visualized Experiments. Dr. Lee was awarded the New Mexico School of Medicine Regents’ Lecturer Award in recognition of his contributions to clinical medicine, research and education. In 2020, he received special recognition from the Department of Veterans Affairs for his team’s response to the COVID-19 pandemic. About the University of Nevada, Reno School of Medicine The University of Nevada, Reno School of Medicine (UNR Med), Nevada’s first public medical school, is a community-based, research-intensive medical school with a statewide vision for a healthy Nevada. Since 1969, UNR Med has trained more than 3,900 students, residents and fellows. UNR Med continues to improve the health and well-being of all Nevadans and their communities through excellence in student education, postgraduate training and clinical care, research with local, national and global impact and a culture of diversity and inclusion. For more information, visit med.unr.edu. About Renown Health Renown Health is the region’s largest, locally governed, not-for-profit integrated healthcare network serving Nevada, Lake Tahoe, and northeast California. With a diverse workforce of more than 7,000 employees, Renown has fostered a longstanding culture of excellence, determination and innovation. The organization comprises a trauma center, two acute care hospitals, a children’s hospital, a rehabilitation hospital, a medical group and urgent care network, and the locally owned not-for-profit insurance company, Hometown Health. For more information, visit renown.org.

    Read More About Samuel Austin Lee, M.D., Ph.D., Appointed Chair of Internal Medicine

    • Monday, Aug 07, 2023

    Dr. William 'Bill' Plauth, Chief Medical Officer for Renown Health; Also Appointed Associate Dean for Clinical Affairs for UNR Med

    William ‘Bill’ Plauth, MD, MMM, CPE, Chief Medical Officer for Renown Health, has also been appointed Associate Dean for Clinical Affairs at the University of Nevada, Reno School of Medicine (UNR Med), effective August 15, 2023. As Associate Dean for Clinical Affairs, Dr. Plauth joins UNR Med in a pivotal role to advance the academic and research integration established under the 2021 affiliation between UNR Med and Renown Health to create Nevada’s first fully integrated health system. Dr. Plauth will provide strategic consultation with UNR Med's Office of Academic Affairs and Office of Medical Research to foster clinical settings that promote and enhance medical education and clinical research within the affiliation. His role is also integral to UNR Med's accreditation and strategic planning processes. “We are thrilled to have Dr. Plauth on board with us”, said Paul J. Hauptman, MD, Dean of UNR Med, and Chief Academic Officer for Renown Health. “Over the last several months, we have worked side-by-side on several important initiatives pertaining to the learning environment. Bill is a strong advocate for our students and residents, and we are confident that this new relationship will be a major step forward in the UNR Med and Renown Health affiliation. We welcome Dr. Plauth to the Wolf Pack family!” “Dr. Plauth is an energetic, collaborative physician and mentor who cares deeply about fostering the next generation of exceptional physicians and physician assistants,” said Brian Erling, MD, MBA, President and CEO, Renown Health. “I know his talent, experience and leadership will do much to advance our shared academic and research mission and further elevate the outstanding care, exceptional training, innovative research, and innovative community partnerships for both UNR and Renown Health.”  As Chief Medical Officer for Renown Health, Dr. Plauth is responsible for resource management, continuous quality improvement, assessment of clinical programs, daily operations, patient safety, and compliance monitoring.   With his additional responsibilities at UNR Med, Dr. Plauth will work with leadership to ensure that medical and physician assistant (PA) students, residents and faculty thrive in a positive clinical learning environment which emphasizes professionalism, teamwork, and clinical quality. Dr. Plauth brings over 30 years of experience in multiple leadership roles, including as Chief Medical Officer at Mercy Regional Medical Center and Centura Penrose & St. Francis Hospitals, all in Colorado. Previously, Dr. Plauth served for fourteen years with CHRISTUS St. Vincent Regional Medical Center in Santa Fe, NM, first as a hospitalist and then as Chief of Staff, Medical Director of Clinical Informatics, Medical Director of Palliative Care, and Acting Chief Medical Officer for Quality and Medical Staff Affairs. He has also served as a medical director of a long-term care and skilled nursing center. Dr. Plauth received his Bachelor of Arts in Economics from the University of Virginia, Charlottesville, and his M.D. degree from Emory University School of Medicine. He completed his internship and residency at the University of California San Francisco, where he served as Chief Resident. Dr. Plauth is board certified by the American Board of Internal Medicine in both Internal Medicine and Hospice & Palliative Care.  The University of Nevada, Reno School of Medicine (UNR Med), Nevada’s first public medical school, is a community-based, research-intensive medical school with a statewide vision for a Healthy Nevada. Since 1969, UNR Med has trained more than 3,900 students, residents and fellows. UNR Med continues to improve the health and well-being of all Nevadans and their communities through excellence in student education, postgraduate training and clinical care, research with local, national and global impact and a culture of diversity and inclusion. For more information, visit med.unr.edu. Renown Health is the region’s largest, locally governed, not-for-profit integrated healthcare network serving Nevada, Lake Tahoe and northeast California. With a diverse workforce of more than 7,000 employees, Renown has fostered a longstanding culture of excellence, determination and innovation. The organization comprises a trauma center, two acute care hospitals, a children’s hospital, a rehabilitation hospital, a medical group and urgent care network, and the locally owned not-for-profit insurance company, Hometown Health. For more information, visit renown.org.

    Read More About Dr. William 'Bill' Plauth, Chief Medical Officer for Renown Health; Also Appointed Associate Dean for Clinical Affairs for UNR Med

    • Monday, May 15, 2023

    Samuel K. Weller Appointed CEO for Renown South Meadows Medical Center and Renown Rehabilitation Hospital

    Renown Health is pleased to announce that Samuel K. Weller, MHPA, will serve as Chief Executive Officer for Renown South Meadows Medical Center, a 118-bed acute care community hospital and Renown Rehabilitation Hospital, a 62-bed physical rehabilitation hospital in Reno, Nev. The position was formerly held by Chris Nicholas, FACHE, who was promoted in March 2022 to serve as CEO of 808-bed Renown Regional Medical Center in Reno. Renown Health is the largest and only locally owned not-for-profit, charitable healthcare network in Reno, serving over 1 million people and 100,000 square miles between Salt Lake City and Sacramento. As CEO, Mr. Weller will work with the South Meadows and Rehabilitation leadership, medical staff, and team to achieve patient care, efficiency, and operational goals.  “We are excited to have Sam join the Renown Health senior leadership team at this pivotal moment in our history,” said Dr. Brian Erling, Renown’s president and CEO. “Sam is a dyamic health care executive with a solid record of advancing acute and ambulatory operations while collaborating with physicians and clinicians to expand services, enhance clinical quality, and exceed customer service expectations. Sam leads with integrity and a people-first approach which are essential to deliver on our mission to improve the health and well-being of the people and communities we serve.” Mr. Weller comes to Renown from Centura Health where he served as Group Vice President of Physician Enterprise for Greater Colorado and Kansas, overseeing physician services across a Level 1 Trauma hospital, eight Level III Trauma hospitals, two Critical Access/Trauma IV hospitals and numerous primary care and specialty practices. He previously served as Director of Strategy and Ambulatory Practices for St. Anthony Summit Medical Center in Summit County, CO overseeing hospital and ambulatory operations for the Rocky Mountain region; and Group Manager Business Development in Denver. Mr. Weller is a graduate of Washington State University with a master’s degree in health policy and administration (MHPA) and a Bachelor of Science degree in Business Finance from Brigham Young University-Idaho. “I love health care because it is about people helping people,” says Sam Weller. “Renown is the most valued and trusted system of health for northern Nevadans, and working together, I am excited to help transform care for our community and improve the quality of life for generations to come.”  South Reno continues to grow, and consumer demand continues to increase for Renown medical providers and facilities. The South Meadows campus, which opened more than 15 years ago in February 2004, is currently improving existing facilities, and expanding service offerings to meet expressed needs of the community. Renown South Meadows Medical Center features private patient rooms for hospital stays, and will add additional private rooms, bringing the total to 73 private rooms when work is done this September.  Weller will assume his new duties on June 26.  Renown South Meadows Medical Center has been nationally recognized for providing the highest quality care and service.  In U.S. News and World Report Best Hospital rankings, Renown South Meadows was listed #1 in the State of Nevada (tied with Carson Tahoe Medical Center) for 2020. Renown South Meadows was rated High Performing for Hip Replacement and Knee Replacement and COPD. A hospital's score is based on multiple data categories, including patient outcomes, safety, and volumes. Hospitals earning a High Performing rating were significantly better than the national average. Renown Regional Medical Center was listed #1 for the State of Nevada in U.S. News and World Report Best Hospital listing for 2021 and 2022.  Sam and the team at Renown South Meadows Medical Center and Renown Rehabilitation Hospital are hiring great physicians, nurses and associates for careers in service; apply online at renown.org/careers, and volunteers to assist patients and their families at renown.org/About/Volunteers. About Renown Health Renown Health is the region’s largest, locally governed, not-for-profit integrated healthcare network serving Nevada, Lake Tahoe and northeast California. With a diverse workforce of more than 7,000 associates, Renown has fostered a longstanding culture of excellence, determination, and innovation. The organization comprises a trauma center, two acute care hospitals, a children’s hospital, a rehabilitation hospital, a medical group and urgent care network, and the region’s largest, locally owned not-for-profit insurance company, Hometown Health. Renown is currently hiring great physicians, nurses and associates for careers in service; apply online at renown.org/careers and volunteers to assist patients and their families at renown.org/About/Volunteers.

    Read More About Samuel K. Weller Appointed CEO for Renown South Meadows Medical Center and Renown Rehabilitation Hospital

    • Thursday, May 11, 2023

    Renown Health Appoints First 'Chief People Officer' to Leadership Team

    Renown Health has added a new face to its executive leadership team. The area’s largest and only locally owned not-for-profit, charitable healthcare network in Reno has named Sandeep Randhawa, MS, as the first Chief People Officer for the organization. Mr. Randhawa joins Renown after nearly a decade with Dignity Health/CommonSpirit Health. As the Chief People Officer, Mr. Randhawa will lead the Human Resources function and continue to develop the purpose-driven culture that supports the personal needs and well-being of Renown’s more than 7,000 exceptional physicians and associates. He will oversee best-in-class talent management programs focused on hiring, training, and managing the performance of the workforce, ensuring that Renown’s values are reinforced with every strategic objective.  “We are excited to welcome Sandeep to Renown and to our community,” said Brian Erling, MD, MBA, Renown’s President and CEO. “As we enter a new era, we have a unique opportunity to reimagine how we promote and grow talent through inclusion and mentorship, how we lead and manage people in a new working environment, and how to use innovative technology to simplify processes and unify our organization. Sandeep leads with integrity and brings a wealth of experience and a people-first approach which are essential to deliver on our mission of improving the health and well-being of the people and communities we serve.”  Mr. Randhawa comes to Renown Health from CommonSpirit Health where he served both as System Vice President for Human Resources Transformation and Integration, and as Southwest Division Vice President, Chief Human Resources Officer. Prior to that, he served as Vice President, Human Resources for Dignity Health in northern California. Much of his leadership career has been dedicated to serving healthcare organizations ranging from hospitals and ambulatory clinics to post-acute care sites and medical group enterprises throughout Arizona, California, Nevada, and southern Utah. “I am excited to honor and celebrate every one of Renown’s physicians, nurses and associates at Renown Health, and to be an active participant in the northern Nevada community,” says Sandeep Randhawa. “I enjoy fostering a culture of positive impact through people, culture, and respect, and connecting people to our mission through service.”  Mr. Randhawa will report directly to the President and CEO of the system, serve as a member of the President’s Council, and will assume his new duties on July 10. Suzanne Oetjen, Director, HR Business Partners who has served as interim Chief HR Officer will work with Mr. Randhawa to ensure a smooth transition of responsibilities. Named one of “America’s Best Employers by State” by Forbes, and the only health system in Nevada to make the list, Renown Health was cited for providing fair pay, safe working conditions, inclusive culture, remote work benefits and diversity initiatives.  Also selected for Ragan’s “Top Places to Work for 2022,” Renown Health fosters a caring culture of values that include caring, integrity, collaboration, and excellence. Renown was awarded for championing the workforce and providing guidance, initiatives and resources that promote a diverse, equitable and inclusive workplace, offering ample room for professional growth and providing effective communication that keeps employees engaged and informed. Renown Health is seeking great employees for careers, apply online at renown.org/careers and for volunteers to assist patients and their families at renown.org/About/Volunteers. About Renown Health Renown Health is the region’s largest, locally governed, not-for-profit integrated healthcare network serving Nevada, Lake Tahoe and northeast California. With a diverse workforce of more than 7,000 employees, Renown has fostered a longstanding culture of excellence, determination and innovation. The organization comprises a trauma center, two acute care hospitals, a children’s hospital, a rehabilitation hospital, a medical group and urgent care network, and the region’s largest, locally owned not-for-profit insurance company, Hometown Health.

    Read More About Renown Health Appoints First 'Chief People Officer' to Leadership Team

    • Monday, Mar 13, 2023

    William 'Bill' Plauth, MD, MMM, CPE Appointed Chief Medical Officer for Renown Health

    Today, Renown Health announced the appointment of William “Bill” Plauth, MD, MMM, CPE as Chief Medical Officer for Renown Health, effective April 3, 2023. “I am excited to have Dr. Plauth join our team," said Brian Erling, MD, MBA, President & CEO of Renown Health. “Dr. Plauth is a distinguished physician with over 30 years of experience. Dr. Plauth’s extensive commitment to service is in alignment with our mission, vision, and values. He is a goal-oriented, collaborative executive who brings a depth of experience to Renown Health and to our community. He inspires others with his intelligence and proven abilities to engage others in advancing clinical quality and performance. I look forward to the strides our health system will make in helping people live better and healthier lives under his leadership.” In his role as Chief Medical Officer (CMO), Dr. Plauth will be responsible for continuous quality improvement, effective clinical resource management and serve as a liaison for organized medical staff activities. He will partner with nursing leadership to actively support performance improvement, risk management, and efficient resource utilization linked to evidence-based medicine. He will listen and foster a close relationship between and among physicians, management, and clinical staff. As CMO, Dr. Plauth will provide expertise, coordination, and leadership in support of elected medical staff leaders and partner with UNR Med leadership to ensure a positive training environment across Renown Health. “As a physician, I have always been humbled by the trust our patients and their families invest in all of us as a healthcare team,” says Bill Plauth, MD. “Over the years, to fulfill that trust, I have enjoyed engaging with my colleagues across clinical teams to adopt innovative approaches that respect those who do the work and to promote ease of practice. Such collaboration makes it possible for us to provide top-notch, compassionate care that addresses our patients' unique challenges and to improve their health and quality of life. At the end of the day, it is the people that make the difference.” Dr. Plauth adds, “I am delighted to join Renown Health, which as a not-for-profit, charitable health care organization has a long history of compassionate service. I look forward to working with my new medical, nursing, and administrative colleagues as we fulfill our mission of making a genuine difference in the health and wellbeing of the people and communities we serve.” Renown Health has more than 7,200 employees and serves Northern Nevada, Lake Tahoe, and Northeast California. The system includes Renown Regional Medical Center, Renown South Meadows Medical Center, Renown Rehabilitation Hospital and Renown Children’s Hospital. Renown also has over 50 medical group, urgent care, and outpatient imaging practices. Hometown Health is the insurance division of Renown Health and is northern Nevada’s largest local, not-for- profit health insurance company that provides wide-ranging medical coverage. Since 2014, Dr. Plauth has provided clinical leadership at Centura Health (CO), first serving as Chief Medical Officer at Mercy Regional Medical Center in Durango, CO, and then for the last four years as Chief Medical Officer for Centura Penrose & St. Francis Hospitals in Colorado Springs. He was responsible for clinical quality, high reliability patient safety initiatives, process improvement, pharmacy, care management, infection control and medical staff services. Formerly, Dr. Plauth served for fourteen years with CHRISTUS St. Vincent Regional Medical Center in Santa Fe, NM, first as a hospitalist and then with concurrent roles that included Chief of Staff; Medical Director, Clinical Informatics; Medical Director, Palliative Care and Acting Chief Medical Officer for Quality and Medical Staff Affairs. Board certified in both Internal Medicine and Hospice & Palliative Care, Dr. Plauth is a leader in quality improvement, patient safety and clinical informatics. He has also served as a medical director of a Long-Term Care and Skilled Nursing Center. Dr. Plauth received his Bachelor of Arts in Economics from the University of Virginia, Charlottesville, and his Medical Doctorate from Emory University in Atlanta with a sub-internship at Brigham and Women’s Hospital in Boston. He completed his internship and residency at University of California San Francisco, where he also served as Chief Resident. In the most recent U.S. News and World Report Best Hospital Rankings, Renown Regional Medical Center is named #1 in the State of Nevada. No other hospital in Nevada earned recognition from U.S. News. About Renown Health Renown Health is Nevada’s largest, not-for-profit integrated healthcare network serving Nevada, Lake Tahoe, and northeast California. With a diverse workforce of more than 7,000 employees, Renown has fostered a longstanding culture of excellence, determination, and innovation. The organization comprises a trauma center, two acute care hospitals, a children’s hospital, a rehabilitation hospital, a medical group and urgent care network, and the locally owned not-for-profit insurance company, Hometown Health. To join the Renown Health team, visit www.renown.org/careers.

    Read More About William 'Bill' Plauth, MD, MMM, CPE Appointed Chief Medical Officer for Renown Health

    • Wednesday, Oct 26, 2022

    Elevated Levels of Arsenic and Other Metals Found In Nevada Private Wells

    Study shows that many household wells need better drinking water treatment and monitoring Outside of Nevada’s bustling cities, private wells are the primary source of drinking water, serving 182,000 people. Yet some of the tested private wells in Nevada are contaminated with levels of heavy metals that exceed federal, state or health-based guidelines, a new study published in Science of The Total Environment shows. Consuming water contaminated by metals such as arsenic can cause adverse health effects. Scientists from DRI and the University of Hawaii Cancer Center recruited households with private wells through the Healthy Nevada Project. Households were sent free water testing kits, and participants were notified of their water quality results and recommended actions they could take. More than 170 households participated in the research, with the majority from Northern Nevada around Reno, Carson City and Fallon. “The goals of the Healthy Nevada project are to understand how genetics, environment, social factors, and healthcare interact. We directly engaged our participants to better understand environmental contaminants that may cause adverse health outcomes,” said co-author Joseph Grzymski, PhD, research professor at DRI, principal investigator of the Healthy Nevada Project®, and chief scientific officer for Renown Health. Nearly one-quarter (22%) of the private wells sampled had arsenic that exceeded safe levels determined by the Environmental Protection Agency (EPA) — with levels 80 times higher than the limit in some cases. Elevated levels of uranium, lead, cadmium, and iron were also found. “We know from previous research that Nevada’s arid climate and geologic landscape produce these heavy metals in our groundwater,” says Monica Arienzo, PhD, an associate research professor at DRI who led the study. “It was important for us to reach out to community members with private wells to see how this is impacting the safety of their drinking water.” Fewer than half (41%) of the wells sampled used water treatment systems, and some treated water samples still contained arsenic levels over EPA guidelines. Although average levels of heavy metal contaminants were lower in treated water, many homes were unable to reduce contaminants to levels considered safe. The state leaves private well owners responsible for monitoring their own water quality, and well water testing helps ensure water is safe to drink. This study shows that more frequent testing is needed to ensure Nevada’s rural communities have safe drinking water. This is particularly important as the effects of climate change and population growth alter the chemistry of groundwater, potentially increasing metal concentrations. “The results emphasize the importance of regular water quality monitoring and treatment systems,” said co-author Daniel Saftner, MS, assistant research scientist at DRI. Although the research focused on wells in Nevada, other arid communities in Western states are facing similar risks of water contamination. More information: The full study, Naturally Occurring Metals in Unregulated Domestic Wells in Nevada, USA, is available from Science of The Total Environment: doi.org/10.1016/j.scitotenv.2022.158277. This project was funded by an NIH award (#1R01ES030948-01). The Healthy Nevada Project was funded by grants from Renown Health and the Renown Health Foundation. Study authors included Monica M. Arienzo (DRI), Daniel Saftner (DRI), Steven N. Bacon (DRI), Erika Robtoy (DRI), Iva Neveux (DRI), Karen Schlauch (DRI), Michele Carbone (University of Hawaii Cancer Center) and Joseph Grzymski (DRI/Renown Health). About DRI The Desert Research Institute (DRI) is a recognized world leader in basic and applied environmental research. Committed to scientific excellence and integrity, DRI faculty, students who work alongside them, and staff have developed scientific knowledge and innovative technologies in research projects around the globe. Since 1959, DRI’s research has advanced scientific knowledge on topics ranging from humans’ impact on the environment to the environment’s impact on humans. DRI’s impactful science and inspiring solutions support Nevada’s diverse economy, provide science-based educational opportunities, and inform policymakers, business leaders, and community members. With campuses in Las Vegas and Reno, DRI serves as the non-profit research arm of the Nevada System of Higher Education. For more information, please visit dri.edu. About Renown Health Renown Health is Nevada’s largest, not-for-profit integrated healthcare network serving Nevada, Lake Tahoe, and northeast California. With a diverse workforce of more than 6,500 employees, Renown has fostered a longstanding culture of excellence, determination, and innovation. The organization comprises a trauma center, two acute care hospitals, a children’s hospital, a rehabilitation hospital, a medical group and urgent care network, and the locally owned not-for-profit insurance company, Hometown Health. Renown is currently enrolling participants in a community-based genetic population health study, the Healthy Nevada Project®. About the University of Hawaiʻi Cancer Center The University of Hawaiʻi Cancer Center through its various activities, including scientific research and clinical trials, adds more than $57 million to the Oʻahu economy. It is one of only 71 research institutions designated by the National Cancer Institute. An organized research unit within the University of Hawaiʻi at Mānoa, the UH Cancer Center is dedicated to eliminating cancer through research, education, patient care and community outreach with an emphasis on the unique ethnic, cultural, and environmental characteristics of Hawaiʻi and the Pacific. Learn more at https://www.uhcancercenter.org. Like us on Facebook at facebook.com/UHCancerCenter. Follow us on Twitter @UHCancerCenter.

    Read More About Elevated Levels of Arsenic and Other Metals Found In Nevada Private Wells

    • Wednesday, Aug 31, 2022

    Hometown Health CEO David Hansen Announces Retirement, Bethany Sexton Named Successor

    Renown Health announced today that David Hansen, CEO will retire on October 7, 2022 from Hometown Health, Nevada’s largest not-for-profit insurance company. Over the last two years that Hansen has overseen Renown’s health plan, he has contributed significantly to ensuring wide-ranging medical coverage and excellent customer service for more than 100,000 members across Nevada. Bethany Sexton, MBA, will assume the role of CEO of Hometown Health effective September 12, 2022 as part of a smooth transition and succession plan. Ms. Sexton currently serves as Chief Transformation Officer for Renown Health, responsible for value-based care delivery including insurance and managed care contracting, the Renown Direct Contracting Entity (DCE), Renown Accountable Care Organization (ACO) and Western Clinical Alliance, a clinically integrated network of physicians. Mr. Hansen led a number of significant accomplishments for Hometown Health including the addition of 82 new provider groups for northern Nevada health plan subscribers and a Medicare network in southern Nevada. Hansen, the Hometown Health team introduced a Transitional Care Navigator program resulting in reduced hospital readmission rates, added Renown-branded insurance products on Nevada Health Link, Nevada’s Health Insurance Exchange and helped to grow Senior Care Plus, Hometown Health’s Medicare Advantage Plan membership during the 2022 Annual Election Period. Hansen and the Hometown Health team implemented a number of Total Cost of Care initiatives in partnership with Renown Medical Group to make premiums and health care costs more affordable, including health outreach efforts and medical screenings to improve health care for members over age 65. "Leading Hometown Health for the past two years, and through the pandemic, has been a great honor. I am incredibly thankful to our members, my fellow employees, our broker and employer partners, and our leadership team for giving me the privilege to serve," said Hansen. “Hometown Health and Renown are community-focused organizations and it has been a privilege to be part of a team that gives back to improve the health and well-being of those we serve. I have spent hours working collaboratively with Bethany over the last few years and know she is perfect person to lead our health plan into a new era.” As CEO, Hansen worked closely with Renown senior leadership to put a thoughtful leadership transition plan in place, culminating with the promotion of Bethany Sexton to the position of CEO. Consistent with the plan, Hansen will continue to offer guidance and perspective as he and Sexton complete the transition over the next few weeks. "David’s vision of excellence, his drive and experience has transformed Hometown Health to be both member and customer-focused,” said Dr. Thomas Graf, CEO of Renown Health. “David has done much to modernize and build a first-rate health plan. We thank David for all his accomplishments and wish him a wonderfully satisfying retirement.” As CEO of Hometown Health, Ms. Sexton will be responsible for driving growth across the organization, including the development and execution of strategic plans; introduction of new programs and services; membership growth; operational, financial and customer service excellence; and continued improvements in clinical quality with a focus on lowering the cost of care for members in northern Nevada. Ms. Sexton has served in a number of key leadership roles for Renown Health over the past eight years, including Vice President of Operations & Development, VP/Administrator for the Department of Medicine, VP Strategic Planning and Performance Improvement, and VP of Revenue Cycle in Finance. With 20 years of health care experience, in both clinical and administrative settings, and more than 9 years at Renown, she has developed collaborative partnerships and created innovative new solutions to meet rapidly changing employee and customer expectations. "I believe one of the most important duties of a leader is preparing the next generation of leadership to succeed," added Dr. Graf. "There is no question that Bethany Sexton is the right person to lead Hometown Health into its next chapter. She has integrity, business acumen, energy, leadership skills and deep knowledge of value based care to ensure Hometown Health delights its membership and she will help Renown Health achieve our strategy of being both a Care Leader and a Health Partner for providers and patients in our community.” Bethany Sexton earned her Master of Business Administration (MBA) from the University of Nevada, Reno and her Bachelor of Arts (B.A.), Business Administration and Management from Western Washington University. She is passionate about community service, most recently serving as Chair, Board of Directors for Immunize Nevada, and as a former Board Member for Nevada Women's Fund, Healthcare Financial Management Association (HFMA) and the American Red Cross. Ms. Sexton and her family make their home in Reno, NV.     About Renown Health Renown Health is the region’s largest, locally governed, not-for-profit integrated healthcare network serving Nevada, Lake Tahoe and northeast California. With a diverse workforce of more than 7,000 employees, Renown has fostered a longstanding culture of excellence, determination and innovation. The organization comprises a trauma center, two acute care hospitals, a children’s hospital, a rehabilitation hospital, a medical group and urgent care network, and the region’s largest, locally owned not-for-profit insurance company, Hometown Health. Renown is currently enrolling participants in the world’s largest community-based genetic population health study, the Healthy Nevada Project®. For more information, visit renown.org.

    Read More About Hometown Health CEO David Hansen Announces Retirement, Bethany Sexton Named Successor

    • Friday, Jul 22, 2022

    Adnan Akbar, MD, Appointed Chief Medical Officer for Renown Acute Care

    Experienced leader to support physicians at Renown Regional and Renown South Meadows Medical Centers Renown Health is pleased to announce that Adnan “Eddy” Akbar, MD, will serve as Chief Medical Officer for Renown Acute Care, overseeing physicians at Renown Regional Medical Center and Renown South Meadows Medical Center. Renown Health is the region's only Level II Trauma Center, serving more than 1 million people and a 100,000 square mile reach – across Nevada, Lake Tahoe and eastern California. Dr. Akbar begins his new role on July 25, succeeding former Chief Medical Officer for Acute Care, Dr. Susan Lee, who was promoted to Chief Operating Officer at Renown South Meadows Medical Center on March 7, 2022. Thomas Graf, MD, CEO for Renown Health, announced Dr. Akbar’s internal promotion today by writing, “Embracing our vision to improve the health of our community, we are empowering leaders to play a greater role in improving physician, employee and patient experiences; growing services to our community; providing Reliable and Exact Care® and meeting rigorous standards for operational excellence and efficiency.” Dr. Graf noted that he was excited as, “Dr. Akbar expands his role, promotes a spirit of unity across the enterprise, and continues to make progress on achieving goals central to Renown’s success.” In his new role as Chief Medical Officer for Acute Care, Dr. Akbar will join Dr. Rahul Mediwala, Chief Medical Officer for Health Services, to lead physicians and clinicians across the Renown enterprise. Dr. Akbar will report directly to Chris Nicholas, Chief Executive Officer for Renown Regional Medical Center. Dr. Akbar is an experienced, dynamic physician executive and operational leader with a record of hospital operations, medical staff leadership and engagement, quality improvement, patient safety, patient experience, risk management, utilization management and clinical documentation improvement. Chris Nicholas, Chief Executive Officer of Renown Regional Medical Center wrote, “Over the last seven years and through all the physician leadership positions he has held, Dr. Akbar has had an intense focus on improving patient care, driving hospital and operational improvements, and demonstrating the best of Renown’s mission, vision and values. Renown has a national reputation for delivering health care that is affordable, accessible and of the highest quality and I look forward to working with Dr. Akbar to engage physicians and administrators in an agenda that supports this vision.” Dr. Susan Lee, Chief Operations Officer of Renown South Meadows Medical Center added, “As we considered the needs of the organization and our future, we determined that Dr. Akbar was the right person to lead physicians across Acute Services. In addition, Dr. Akbar has demonstrated strong and engaging leadership with physicians, nurses, the senior management team and across our hospitals and we are confident in Eddy’s ability to contribute to the great progress that Renown Health is making in becoming the best place to practice medicine and to receive care.” Dr. Akbar has been with Renown Health for seven years, previously serving as Secretary of Medical Staff, an Internal Medicine physician, Chair of the Department of Medicine, Division Chief for Hospital Medicine and most recently as a hospitalist physician of Renown Medical Group and Associate Chief Medical Officer of Renown Regional Medical Center. Dr. Akbar is an Assistant Professor of Medicine at University of Nevada-Reno, School of Medicine and a member of the Clinical Faculty at St. Georges University School of Medicine, Grenada. Dr. Akbar is fluent in four languages including Urdu, Pushto and Hindi. Dr. Akbar completed his residency in internal medicine at Cleveland Clinic. He is a Diplomat of the American Board of Internal Medicine, and earned his medical degree from Aga Khan Medical College in Karachi, Pakistan. Dr. Akbar is completing his master’s in healthcare administration from Cornell University. Dr. Akbar’s research interests include observation criteria and appropriate utilization management of hospitalized patients, development and usage of dedicated Epic order sets to improve patient care and outcomes, advancement and development of Milestone appropriate care during acute hospitalization and transitional care policies to reduce hospital readmissions and improve patient care. In U.S. News and World Report Best Hospitals rankings, Renown Regional is #1 in the State of Nevada for 2021. No other hospital in Nevada earned recognition from U.S. News. Renown South Meadows was listed #1 in the State of Nevada (tied with Carson Tahoe Medical Center) for 2021. Renown Regional Medical Center is High Performing, its highest rating possible, for Heart Failure, Colon Cancer Surgery and Chronic Obstructive Pulmonary Disease. Renown South Meadows was rated High Performing for Hip Replacement and Knee Replacement and COPD. A hospital's score is based on multiple data categories, including patient outcomes, safety and volumes. Hospitals earning a High Performing rating were significantly better than the national average. The team at Renown Health is seeking great employees for careers in service; apply online at https://careers.renown.org/. About Renown Health Renown Health is the region’s largest, locally governed, not-for-profit integrated healthcare network serving Nevada, Lake Tahoe and northeast California. With a diverse workforce of more than 7,000 employees, Renown has fostered a longstanding culture of excellence, determination and innovation. The organization comprises a trauma center, two acute care hospitals, a children’s hospital, a rehabilitation hospital, a medical group and urgent care network, and the region’s largest, locally owned not-for-profit insurance company, Hometown Health. Renown is currently enrolling participants in the world’s largest community-based genetic population health study, the Healthy Nevada Project®.

    Read More About Adnan Akbar, MD, Appointed Chief Medical Officer for Renown Acute Care

    • Wednesday, Apr 27, 2022

    Study Shows Importance of Ensuring Participant and Provider Follow-up After a Genetic Screening Result

    Released in partnership with the Desert Research Institute: New research from the Healthy Nevada Project® finds that a confirmed diagnosis does not always result in changes to patient care. Presenting individuals with potentially life-altering health information doesn’t mean the individuals – or their healthcare providers – will act on it. Follow-up education and conversations about actionable care plans with patients and their doctors are key next steps, according to new research from the Healthy Nevada Project.  The Healthy Nevada Project is a genetic screening and research project that launched in 2016 as a partnership between DRI and Renown Health. The project now has more than 50,000 participants, with genetic sequencing provided by Helix.  Between September 2018 and September 2020, the Healthy Nevada Project successfully notified 293 participants that they were genetically at risk for hereditary breast and ovarian cancer syndrome, Lynch syndrome, or familial hypercholesterolemia – three common genetic conditions known collectively as the Centers for Disease Control and Prevention (CDC) Tier 1 conditions. In a study published today in Frontiers in Genetics, Healthy Nevada Project scientists looked at the impact that notifying a patient of a positive finding for a CDC Tier 1 condition had on the care that the patient received in the months and years that followed.  According to their results, among the 293 Healthy Nevada Project participants who were notified of their genetic risk of a CDC Tier 1 condition, 71 percent of participants with electronic health records shared their findings with healthcare providers. However, only 30 percent of the electronic health records for these patients contained documentation of the genetic diagnosis, and only 10 percent of examined patients experienced a possible change in care after receiving the results of their genetic screening.  “The Healthy Nevada Project was implemented with a ‘hands-off’ approach where the participants receive their findings and decide with whom and when to share those findings. The findings were not automatically added to their electronic health records,” said Dr. Gai Elhanan, health data scientist at DRI and co-lead author of the study. “What we’re learning now is that to ensure that important genetic findings are integrated into the care journey it is important to make their inclusion into the electronic health records part of the study.” This study builds on previous Healthy Nevada Project research published in Nature Medicine demonstrating the importance of screening for CDC Tier 1 conditions, which affect about one in 75 individuals and can be mitigated or even prevented from developing into disease when detected early. This study found that as many as 90 percent of the CDC Tier 1 cases are missed by clinical providers during normal clinical care screenings and examinations. During the current study, the Healthy Nevada Project scientists found that 19 percent of studied participants had already developed one of the CDC Tier 1 conditions, and thus would have potentially benefited from earlier notification about their condition. The study team hopes that their findings will encourage individuals in Nevada to obtain genetic testing for these relatively common conditions. Even if individuals are older or have already suffered from diseases related to these conditions, testing could also prove beneficial to siblings, children, and grandchildren who may also be at risk and who could subsequently be screened in the event of a positive finding. The study team also encourages informing health care providers of the importance of incorporating genetic diagnoses into the pharmaceutical (for example, for Familial Hypercholesterolemia) and treatment advice given to patients.  “As a result of this analysis, the clinicians at Renown Health and the Healthy Nevada Project researchers have made significant changes, including obtaining informed consent from participants to report positive findings from their genetics reports directly into their electronic medical record,” said Daniel Kiser, M.S., assistant research scientist of data science at DRI and co-lead author of the study. “This will help both participants, their clinical providers, and the whole state maximize the long-term benefits of the Healthy Nevada Project voluntary population-based genetic screening.” Additional information: The full text of the study,  Incomplete Penetrance of Population-Based Genetic Screening Results in Electronic Health Record, is available from Frontiers in Genetics: https://www.frontiersin.org/articles/10.3389/fgene.2022.866169/full?&utm_source=Email_to_authors_&utm_medium=Email&utm_content=T1_11.5e1_author&utm_campaign=Email_publication&field=&journalName=Frontiers_in_Genetics&id=866169.  This project was funded by Renown Health, the Renown Health Foundation, and the Nevada Governor’s Office of Economic Development. Study authors included Gai Elhanan (DRI), Daniel Kiser (DRI), Iva Neveux (DRI), Shaun Dabe (Renown Health), Alexander Bolze (Helix), William Metcalf (DRI), James Lu (Helix), and Joseph Grzymski (DRI/Renown Health). For more information on the Healthy Nevada Project® or to request genetic screening, please visit: https://healthynv.org/ About DRI The Desert Research Institute (DRI) is a recognized world leader in basic and applied environmental research. Committed to scientific excellence and integrity, DRI faculty, students who work alongside them, and staff have developed scientific knowledge and innovative technologies in research projects around the globe. Since 1959, DRI’s research has advanced scientific knowledge on topics ranging from humans’ impact on the environment to the environment’s impact on humans. DRI’s impactful science and inspiring solutions support Nevada’s diverse economy, provide science-based educational opportunities, and inform policymakers, business leaders, and community members. With campuses in Las Vegas and Reno, DRI serves as the non-profit research arm of the Nevada System of Higher Education. For more information, please visit www.dri.edu. About Renown Health Renown Health is the region’s largest, locally governed, not-for-profit integrated healthcare network serving Nevada, Lake Tahoe and northeast California. With a diverse workforce of more than 7,000 employees, Renown has fostered a longstanding culture of excellence, determination and innovation. The organization comprises a trauma center, two acute care hospitals, a children’s hospital, a rehabilitation hospital, a medical group and urgent care network, and the region’s largest, locally owned not-for-profit insurance company, Hometown Health. Renown is currently enrolling participants in the world’s largest community-based genetic population health study, the Healthy Nevada Project®. For more information, visit renown.org. About Helix Helix is the leading population genomics and viral surveillance company operating at the intersection of clinical care, research, and data analytics. Helix enables health systems, life sciences companies, payers, and government partners to accelerate the integration of genomic data into patient care and public health decision making. Learn more at www.helix.com.

    Read More About Study Shows Importance of Ensuring Participant and Provider Follow-up After a Genetic Screening Result

Number of results found: 35
Use this additional navigation to go to the next pages. Use tab and enter keyboard keys to navigate the menu 1 Page # 2 Page # 3 Navigate to next page Page 1 of 3
Skipped to 35 results found. Page 1 of 3